Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies

Cancer Immunology, Immunotherapy : CII
Upendra P Hegde, Bijay Mukherji

Abstract

Adoptive cell therapies with chimeric antigen receptor (CAR) engineered T cells (CAR-T) and immune checkpoint inhibition (ICI)-based cancer immunotherapies have lately shown remarkable success in certain tumor types. CAR-T cell-based therapies targeting CD19 can now induce durable remissions as well as prolong disease-free survival of patients with CD19 positive treatment refractory B cell malignancies and ICI-based therapies with humanized monoclonal antibodies against the T cell inhibitory receptors CTLA-4 and PD-1 as well as against the PD-1 ligand, PD-L1, can now achieve durable remissions as well as prolongation of life of a sizeable fraction of patients with melanoma and Hodgkin's lymphoma and non-small cell cancers. Most importantly, these immuno-therapeutic treatment modalities have raised the possibility of achieving long-term "containment" as well as "cures" for certain types of cancer. While this represents major advances in cancer immunotherapy, both modalities come with considerable toxicities, including fatalities. Although more work will be needed to bring CAR-T cell-based therapies to the bedside for most major cancers and a good deal more will be needed to make ICI-alone or in combination with other treatment m...Continue Reading

References

Dec 1, 1992·The Journal of Experimental Medicine·P S LinsleyN K Damle
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G GrossZ Eshhar
Dec 31, 1987·Biochemical and Biophysical Research Communications·Y KuwanaY Kurosawa
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Feb 15, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julie R ParkMichael C Jensen
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Nov 13, 2007·The Journal of Urology·Harry W Herr, Alvaro Morales
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberEvan Hersh
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis H CamachoAntoni Ribas
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
Mar 23, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael C JensenStephen J Forman
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerSuzanne L Topalian
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Apr 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven A RosenbergMark E Dudley
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Oct 25, 2011·Nature Reviews. Cancer·Padmanee SharmaJames P Allison
Jan 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter A PrietoGiao Q Phan
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Apr 5, 2012·AIDS·Tae-Wook Chun, Anthony S Fauci
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Dec 21, 2013·Science·Jennifer Couzin-Frankel
Dec 24, 2013·Current Opinion in Pediatrics·David M BarrettStephan A Grupp
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand

❮ Previous
Next ❯

Citations

Jul 18, 2019·Critical Reviews in Clinical Laboratory Sciences·Mansour PoorebrahimAngel Cid-Arregui
Sep 11, 2020·Neurologia Medico-chirurgica·Ryota Tamura, Masahiro Toda
Nov 23, 2017·Immunology·Graham Pawelec
Jul 25, 2018·Annals of Surgical Oncology·Toan PhamRobert Ramsay
Oct 24, 2019·Journal of Hematology & Oncology·Yuan MaoQi Tang
Nov 10, 2017·International Journal of Cancer. Journal International Du Cancer·Maria-Luisa SchubertMichael Schmitt
Oct 20, 2017·Expert Review of Anticancer Therapy·Jinjing XuJunnian Zheng
Jul 15, 2018·Seminars in Immunopathology·Graham Pawelec
Jan 26, 2021·Frontiers in Oncology·Jiaqiao FanJianxun Song
Mar 12, 2018·Leukemia Research·Fang ZhuReginald M Gorczynski
May 22, 2021·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yeison Santamaria-Alza, Gloria Vasquez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Discovery Medicine
Claudia Voena, Roberto Chiarle
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Elodie PicardaXingxing Zang
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Takashi Inozume
[Rinshō ketsueki] The Japanese journal of clinical hematology
Yutaka Kawakami
© 2022 Meta ULC. All rights reserved